Cargando…
Influences of different dose of tirofiban for acute ST elevation myocardial infarction patients underwent percutaneous coronary intervention
Tirofiban is widely used in patients with acute ST elevation myocardial infarction (STEMI) underwent percutaneous coronary intervention (PCI). This drug can efficiently improve myocardial perfusion and cardiac function, but its dose still remains controversial. We here investigated the effects of di...
Autores principales: | Wang, Haixia, Feng, Meiqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306376/ https://www.ncbi.nlm.nih.gov/pubmed/32501985 http://dx.doi.org/10.1097/MD.0000000000020402 |
Ejemplares similares
-
Prediction of no-reflow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction
por: Yang, Li, et al.
Publicado: (2020) -
Association between RDW and stent thrombosis in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
por: Tunçez, Abdullah, et al.
Publicado: (2017) -
The triglyceride-glucose index and contrast-induced nephropathy in non-ST elevation myocardial infarction patients undergoing percutaneous coronary intervention
por: Gursoy, Erol, et al.
Publicado: (2023) -
Rapid Early Triage by Leukocytosis and the Thrombolysis in Myocardial Infarction (TIMI) Risk Score for ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: An Observational Study
por: Yeh, Yen-Ting, et al.
Publicado: (2016) -
Serum Apelin Level Predicts the Major Adverse Cardiac Events in Patients With ST Elevation Myocardial Infarction Receiving Percutaneous Coronary Intervention
por: Liu, Hai-Tao, et al.
Publicado: (2015)